Minomic is pleased to announce the appointment of Dr Chih-Ling Zao as its US Laboratory Director.
Chih-Ling is an American Board of Bioanalysis certified high-complexity Laboratory Director with over ten years’ extensive diagnostic laboratory experience in the specialities of chemistry, immunology, infectious disease and molecular genetics.
Reflecting on her appointment Dr Zao said: “I am excited to join the team in this milestone moment to launch its diagnostic service in the U.S.”
“As lab director, I’ll be striving to provide high-quality and fast turnaround testing services with MiCheck® Prostate.”
The appointment is a major boost for Minomic which is progressing rapidly in its commercialisation of the test in one of the world’s largest markets.
“We’re delighted to welcome Chih-Ling to the team. She has a wealth of experience in labs and will be crucial to a successful rollout of the test in the US,” said Minomic CEO Dr Brad Walsh.
“MiCheck® Prostate seeks to address an unmet need for a test to detect aggressive prostate cancers and thus to accurately triage appropriate patients for biopsy or active surveillance.”
“Through Chih-Ling’s stewardship, Minomic will work to positively impact the lives of American patients.”
